Protect Pharmaceutical Stock Market Capitalization
| PRTT Stock | USD 0.91 0.03 3.41% |
Protect Pharmaceutical fundamentals help investors to digest information that contributes to Protect Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Protect Pink Sheet. The fundamental analysis module provides a way to measure Protect Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Protect Pharmaceutical pink sheet.
Protect |
Protect Pharmaceutical Company Market Capitalization Analysis
Protect Pharmaceutical's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Protect Pharmaceutical Market Capitalization | 2.5 M |
Most of Protect Pharmaceutical's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Protect Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Protect Pharmaceutical is about 2.5 M. This is 99.96% lower than that of the Pharmaceuticals sector and 99.86% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.99% higher than that of the company.
Protect Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Protect Pharmaceutical's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Protect Pharmaceutical could also be used in its relative valuation, which is a method of valuing Protect Pharmaceutical by comparing valuation metrics of similar companies.Protect Pharmaceutical is currently under evaluation in market capitalization category among its peers.
Protect Fundamentals
| Current Valuation | 2.6 M | |||
| Shares Outstanding | 1.11 M | |||
| Shares Owned By Insiders | 84.30 % | |||
| Price To Earning | (23.96) X | |||
| EBITDA | (115.4 K) | |||
| Net Income | (122.61 K) | |||
| Cash And Equivalents | 20.07 K | |||
| Total Debt | 101 K | |||
| Current Ratio | 0.40 X | |||
| Book Value Per Share | (0.01) X | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 11 | |||
| Beta | 2.38 | |||
| Market Capitalization | 2.5 M | |||
| Retained Earnings | (9.37 M) | |||
| Working Capital | (33 K) | |||
| Current Liabilities | 33 K | |||
| Z Score | 14.4 |
About Protect Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Protect Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Protect Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Protect Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Protect Pink Sheet Analysis
When running Protect Pharmaceutical's price analysis, check to measure Protect Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protect Pharmaceutical is operating at the current time. Most of Protect Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Protect Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protect Pharmaceutical's price. Additionally, you may evaluate how the addition of Protect Pharmaceutical to your portfolios can decrease your overall portfolio volatility.